FibroGen Stock Bearish Momentum With A 32% Drop In The Last 21 Sessions
FibroGen (NASDAQ:FGEN), a biopharmaceutical company trading under NASDAQ, experienced an astounding 32.03% drop over 21 sessions – this large drop stands out against the overall increase of just 0.019% on NASDAQ. This indicates specific factors are impacting FibroGen shares. Market Performance & Ongoing Developments FibroGen closed with its closing price being 92.6% below its 52-week…